1. Home
  2. FEMY vs TACT Comparison

FEMY vs TACT Comparison

Compare FEMY & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$0.57

Market Cap

37.2M

Sector

Health Care

ML Signal

N/A

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

N/A

Current Price

$3.25

Market Cap

37.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
TACT
Founded
2004
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
37.2M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
FEMY
TACT
Price
$0.57
$3.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.50
$5.00
AVG Volume (30 Days)
407.0K
22.2K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
8.60
N/A
EPS
N/A
N/A
Revenue
$1,629,108.00
N/A
Revenue This Year
$64.02
$21.67
Revenue Next Year
$147.19
$7.63
P/E Ratio
N/A
N/A
Revenue Growth
51.97
N/A
52 Week Low
$0.31
$3.22
52 Week High
$1.76
$5.70

Technical Indicators

Market Signals
Indicator
FEMY
TACT
Relative Strength Index (RSI) 54.28 33.34
Support Level $0.54 N/A
Resistance Level $0.58 $3.89
Average True Range (ATR) 0.03 0.19
MACD 0.01 -0.02
Stochastic Oscillator 80.26 12.50

Price Performance

Historical Comparison
FEMY
TACT

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: